Building firm foundations for therapy development

J Natl Cancer Inst. 2015 Feb 20;107(3):djv016. doi: 10.1093/jnci/djv016. Print 2015 Mar.

Authors

James J Dignam¹, Theodore G Karrison²

Affiliations

¹ Department of Public Health Sciences, University of Chicago (JJD, TGK). jdignam@health.bsd.uchicago.edu.
² Department of Public Health Sciences, University of Chicago (JJD, TGK).

PMID: 25710961
DOI: 10.1093/jnci/djv016

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Antineoplastic Agents / administration & dosage*
Antineoplastic Agents / adverse effects*
Clinical Trials, Phase I as Topic / methods*
Dose-Response Relationship, Drug*
Humans
Maximum Tolerated Dose*
Research Design*

Substances

Antineoplastic Agents

Grant support